Skip to main content

Table 3 Postoperative characteristics of patients among two groups

From: The effect of neostigmine on postoperative delirium after colon carcinoma surgery: a randomized, double-blind, controlled trial

 

Group N

(n = 196)

Group P

(n = 205)

P-value

POD, n (%)

38(19.39%)

43(20.98%)

0.692

POD duration n, (%)

  

0.928

 Non-POD n, (%)

158(80.61%)

162(79.02%)

 

 0 to 6 h n, (%)

22(11.22%)

26(12.68%)

 

 6 to 12 h n, (%)

9(4.59%)

11(5.37%)

 

 > 12 h n, (%)

7(3.57%)

6(2.93%)

 

Postoperative MDAS score (point, \(\overline x\) ± s)

8.17 ± 3.44

8.36 ± 3.37

0.571

Postoperative 24 h NRS score (point, \(\overline x\) ± s)

1.98 ± 1.29

2.06 ± 1.22

0.505

Abnormal muscle weakness, n (%)

0(0%)

0(0%)

 

PONV, n (%)

24(12.24%)

22(10.73%)

0.635

Gastrointestinal complications, n (%)

35(17.86%)

48(23.41%)

0.170

Wound bleeding and infection, n (%)

13(6.63%)

17(8.29%)

0.528

POPCs, n (%)

42(21.43%)

63(30.73%)

0.034*

Cardiac complications, n (%)

3(1.53%)

2(0.98%)

0.679

Cerebrovascular complications, n (%)

1(0.51%)

2(0.98%)

1.000

Postoperative hospital stay (day, \(\overline x\) ± s)

12.44 ± 2.78

12.54 ± 2.50

0.726

Mortality in 6 months, n (%)

3(1.53%)

4(1.96%)

1.000

  1. Abbreviation: PONV Postoperative nausea and vomiting, POPCs Postoperative pulmonary complications
  2. *P < 0.05 in comparison with group P